70 related articles for article (PubMed ID: 29661714)
1. microRNA 155 up regulation in the CNS is strongly correlated to Down's syndrome dementia.
Tili E; Mezache L; Michaille JJ; Amann V; Williams J; Vandiver P; Quinonez M; Fadda P; Mikhail A; Nuovo G
Ann Diagn Pathol; 2018 Jun; 34():103-109. PubMed ID: 29661714
[TBL] [Abstract][Full Text] [Related]
2. DYRK1A Regulates the Bidirectional Axonal Transport of APP in Human-Derived Neurons.
Fernandez Bessone I; Navarro J; Martinez E; Karmirian K; Holubiec M; Alloatti M; Goto-Silva L; Arnaiz Yepez C; Martins-de-Souza D; Minardi Nascimento J; Bruno L; Saez TM; Rehen SK; Falzone TL
J Neurosci; 2022 Aug; 42(33):6344-6358. PubMed ID: 35803734
[No Abstract] [Full Text] [Related]
3. Multi-Modal Imaging in Down's Syndrome: Maximizing Utility Through Innovative Neuroimaging Approaches.
Brown SSG; Mak E; Zaman S
Front Neurol; 2020; 11():629463. PubMed ID: 33488507
[TBL] [Abstract][Full Text] [Related]
4. Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer's Disease.
Lee JY; Han SH; Park MH; Baek B; Song IS; Choi MK; Takuwa Y; Ryu H; Kim SH; He X; Schuchman EH; Bae JS; Jin HK
Nat Commun; 2018 Apr; 9(1):1479. PubMed ID: 29662056
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Severity of Alzheimer Disease in Individuals With Down Syndrome.
Rafii MS; Santoro SL
JAMA Neurol; 2019 Feb; 76(2):142-143. PubMed ID: 30452497
[No Abstract] [Full Text] [Related]
6. Inhibition of microRNA-155 Alleviates Cognitive Impairment in Alzheimer's Disease and Involvement of Neuroinflammation.
Liu D; Zhao D; Zhao Y; Wang Y; Zhao Y; Wen C
Curr Alzheimer Res; 2019; 16(6):473-482. PubMed ID: 31456514
[TBL] [Abstract][Full Text] [Related]
7. From understanding to action: Exploring molecular connections of Down syndrome to Alzheimer's disease for targeted therapeutic approach.
Sukreet S; Rafii MS; Rissman RA
Alzheimers Dement (Amst); 2024; 16(2):e12580. PubMed ID: 38623383
[TBL] [Abstract][Full Text] [Related]
8. Role of microRNAs in cognitive decline related to COVID‑19 (Review).
Bougea A; Georgakopoulou VE; Lempesis IG; Fotakopoulos G; Papalexis P; Sklapani P; Trakas N; Spandidos DA; Angelopoulou E
Exp Ther Med; 2024 Apr; 27(4):139. PubMed ID: 38476899
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of miR-155 on nonmodifiable and modifiable risk factors in Alzheimer's disease.
Liu JJ; Long YF; Xu P; Guo HD; Cui GH
Alzheimers Res Ther; 2023 Jul; 15(1):122. PubMed ID: 37452431
[TBL] [Abstract][Full Text] [Related]
10. miRNAs as a Potential Biomarker in the COVID-19 Infection and Complications Course, Severity, and Outcome.
Jankovic M; Nikolic D; Novakovic I; Petrovic B; Lackovic M; Santric-Milicevic M
Diagnostics (Basel); 2023 Mar; 13(6):. PubMed ID: 36980399
[TBL] [Abstract][Full Text] [Related]
11. The amplification of CNS damage in Alzheimer's disease due to SARS-CoV2 infection.
Nuovo GJ; Suster D; Sawant D; Mishra A; Michaille JJ; Tili E
Ann Diagn Pathol; 2022 Dec; 61():152057. PubMed ID: 36334414
[TBL] [Abstract][Full Text] [Related]
12. Cognitive dysfunction associated with COVID-19: Prognostic role of circulating biomarkers and microRNAs.
Alvarez M; Trent E; Goncalves BS; Pereira DG; Puri R; Frazier NA; Sodhi K; Pillai SS
Front Aging Neurosci; 2022; 14():1020092. PubMed ID: 36268187
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-Based Diagnosis and Therapeutics for Vascular Cognitive Impairment and Dementia.
Zhai W; Zhao M; Zhang G; Wang Z; Wei C; Sun L
Front Neurol; 2022; 13():895316. PubMed ID: 35592472
[TBL] [Abstract][Full Text] [Related]
14. Profiling of circulating chromosome 21-encoded microRNAs, miR-155, and let-7c, in down syndrome.
Pérez-Villarreal JM; Aviña-Padilla K; Beltrán-López E; Guadrón-Llanos AM; López-Bayghen E; Magaña-Gómez J; Meraz-Ríos MA; Varela-Echavarría A; Angulo-Rojo C
Mol Genet Genomic Med; 2022 Jun; 10(6):e1938. PubMed ID: 35411714
[TBL] [Abstract][Full Text] [Related]
15. Differential microRNA expression profile in blood of children with Down syndrome suggests a role in immunological dysfunction.
Biselli JM; Zampieri BL; Biselli-Chicote PM; de Souza JES; Bürger MC; da Silva WA; Goloni-Bertollo EM; Pavarino ÉC
Hum Cell; 2022 Mar; 35(2):639-648. PubMed ID: 35060072
[TBL] [Abstract][Full Text] [Related]
16. Aging with Down Syndrome-Where Are We Now and Where Are We Going?
Alldred MJ; Martini AC; Patterson D; Hendrix J; Granholm AC
J Clin Med; 2021 Oct; 10(20):. PubMed ID: 34682809
[TBL] [Abstract][Full Text] [Related]
17. Small Neuron-Derived Extracellular Vesicles from Individuals with Down Syndrome Propagate Tau Pathology in the Wildtype Mouse Brain.
Ledreux A; Thomas S; Hamlett ED; Trautman C; Gilmore A; Rickman Hager E; Paredes DA; Margittai M; Fortea J; Granholm AC
J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501378
[TBL] [Abstract][Full Text] [Related]
18. miR-155 as an Important Regulator of Multiple Sclerosis Pathogenesis. A Review.
Maciak K; Dziedzic A; Miller E; Saluk-Bijak J
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919306
[TBL] [Abstract][Full Text] [Related]
19. Endosome Dysregulation in Down Syndrome: A Potential Contributor to Alzheimer Disease Pathology.
Filippone A; Praticò D
Ann Neurol; 2021 Jul; 90(1):4-14. PubMed ID: 33547827
[TBL] [Abstract][Full Text] [Related]
20. The BACH1/Nrf2 Axis in Brain in Down Syndrome and Transition to Alzheimer Disease-Like Neuropathology and Dementia.
Perluigi M; Tramutola A; Pagnotta S; Barone E; Butterfield DA
Antioxidants (Basel); 2020 Aug; 9(9):. PubMed ID: 32839417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
